Status:

COMPLETED

Silk Protein Microparticle-based Filler for Injection Augmentation

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

Sofregen Medical, Inc.

Conditions:

Vocal Cord Paralysis Unilateral

Dysphonia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will investigate the safety and efficacy of a silk protein microparticle-based filler for vocal fold injection augmentation to treat dysphonia/dysphagia secondary to vocal fold paralysis. P...

Detailed Description

Vocal fold paralysis is a clinical condition that arises commonly as a complication of surgery, endotracheal intubation, malignancy, or idiopathic etiologies. It often results in glottal insufficiency...

Eligibility Criteria

Inclusion

  • Unilateral vocal fold immobility with glottal insufficiency present for at least 2 weeks from onset
  • Willingness to partake in study and follow-up as documented by signed informed consent

Exclusion

  • History of allergy/hypersensitivity to silk or silk containing products
  • History of allergy/hypersensitivity to hyaluronic acid (HA) or HA containing products
  • History of allergy/hypersensitivity to lidocaine or amide-based anesthetics
  • History of an autoimmune condition
  • Significant immunocompromised state (i.e. immunosuppression s/p transplantation)
  • Pregnancy
  • Active infection or inflammation in the larynx
  • Comorbid known laryngeal conditions including but not limited to vocal fold scar, vocal tremor, laryngeal dystonia, etc. that would warrant other interventions for optimal treatment
  • History of laryngeal surgery
  • Life expectancy of less than 6 months

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2023

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT03790956

Start Date

July 1 2020

End Date

March 15 2023

Last Update

May 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Southern California

Los Angeles, California, United States, 90033

Silk Protein Microparticle-based Filler for Injection Augmentation | DecenTrialz